Loss Per Share (Tables)

12 Months Ended

Dec. 31, 2025

Antidilutive Securities Excluded from Computation of Earnings Per Share

The following potentially dilutive securities have been excluded from the computations of diluted weighted average shares outstanding as of December 31, 2025 and 2024 as the inclusion thereof would have been anti-dilutive:



	Year Ended December 31,
	2025 (Shares)		2024 (Shares)
Warrants to purchase shares of common stock		4,172,144		9,595,940
Options to purchase shares of common stock		6,572,509		6,854,758
Shares of common stock issuable upon conversion of convertible notes payable – related party		7,631,297		7,024,053
Shares of common stock issuable upon conversion of convertible line of credit – related party		33,103,415		25,103,873
Restricted stock vesting in January 2026		334,000		—
Shares of common stock issuable upon conversion preferred stock		495,007		499,174
		52,308,372		49,077,798